Germany's Bayer said on Friday the U.S. Food and Drug Administration has approved its drug for menopause relief.
The drug, one of the few nonhormonal options for menopausal women, reduced hot flashes and night sweats, and appears to help ...
Elanco Animal Health said on Friday it had received an emergency use authorization from the U.S. Food and Drug Administration ...
Health and Human Services Secretary Robert F. Kennedy Jr. determined that New World screwworm presents significant potential ...
The Independent on MSN
FDA approves new pill for menopausal women to treat hot flashes and night sweats
“The FDA approval of Lynkuet is an important new option for women and providers who are treating moderate to severe hot ...
The U.S. Food and Drug Administration is urging people to avoid eating, selling or serving eggs from the Arkansas-based Black ...
The FDA approved revumenib for patients aged 1 year and older with relapsed or refractory acute myeloid leukemia with a ...
Cardiff Oncology (CRDF) is a speculative buy with potential blockbuster gains ahead of its 2026 data readout. Read here for ...
The US Food and Drug Administration has approved another once-a-day pill that works without hormones to treat moderate to ...
Food and Drug Administration has approved British drugmaker GSK's blood cancer drug, Blenrep, in one combination regimen, the ...
The FDA has approved once-daily oral Lynkuet for the treatment of moderate to severe hot flashes caused by menopause, ...
Since interagency cooperation isn’t succeeding organically, it’s time for top-down initiatives led by a Health and Human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback